FDA Accelerates Approval of Afamitresgene Autoleucel for Advanced Synovial Sarcoma Sarcoma 2 Mins Read10 Introduction On August 2, 2024, the FDA granted accelerated approval to afamitresgene autoleucel (TECELRA) for treating adults with unresectable or…
